ContextVision AB (CONTX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ContextVision AB (CONTX) has a cash flow conversion efficiency ratio of 0.048x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr4.44 Million ≈ $467.32K USD) by net assets (Nkr92.16 Million ≈ $9.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ContextVision AB - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how ContextVision AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read CONTX total debt and obligations for a breakdown of total debt and financial obligations.
ContextVision AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ContextVision AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GeneMatrix Inc
KQ:109820
|
0.027x |
|
Food and Drinks Public Company Limited
BK:F&D
|
0.004x |
|
EMB Mission Bound AB (publ)
ST:NAVIGO-STAM
|
0.033x |
|
Advancecon Holdings Bhd
KLSE:5281
|
0.155x |
|
NextCure Inc
NASDAQ:NXTC
|
-0.265x |
|
Advance Metals Ltd
AU:AVM
|
-0.047x |
|
Xavis Co. Ltd
KQ:254120
|
0.045x |
|
Utron Ltd
TA:UTRN
|
0.127x |
Annual Cash Flow Conversion Efficiency for ContextVision AB (2002–2025)
The table below shows the annual cash flow conversion efficiency of ContextVision AB from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see ContextVision AB market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Nkr92.16 Million ≈ $9.70 Million |
Nkr4.44 Million ≈ $467.32K |
0.048x | -86.21% |
| 2024-12-31 | Nkr94.26 Million ≈ $9.92 Million |
Nkr32.94 Million ≈ $3.47 Million |
0.349x | -39.23% |
| 2023-12-31 | Nkr77.83 Million ≈ $8.19 Million |
Nkr44.75 Million ≈ $4.71 Million |
0.575x | +47.76% |
| 2022-12-31 | Nkr66.53 Million ≈ $7.00 Million |
Nkr25.89 Million ≈ $2.72 Million |
0.389x | +55.29% |
| 2021-12-31 | Nkr37.80 Million ≈ $3.98 Million |
Nkr9.47 Million ≈ $996.83K |
0.251x | -10.41% |
| 2020-12-31 | Nkr79.78 Million ≈ $8.40 Million |
Nkr22.32 Million ≈ $2.35 Million |
0.280x | -26.23% |
| 2019-12-31 | Nkr66.14 Million ≈ $6.96 Million |
Nkr25.08 Million ≈ $2.64 Million |
0.379x | +333.76% |
| 2018-12-31 | Nkr58.56 Million ≈ $6.16 Million |
Nkr5.12 Million ≈ $538.67K |
0.087x | +166.30% |
| 2017-12-31 | Nkr59.35 Million ≈ $6.24 Million |
Nkr1.95 Million ≈ $204.99K |
0.033x | -78.84% |
| 2016-12-31 | Nkr61.43 Million ≈ $6.46 Million |
Nkr9.53 Million ≈ $1.00 Million |
0.155x | -3.38% |
| 2015-12-31 | Nkr57.04 Million ≈ $6.00 Million |
Nkr9.16 Million ≈ $963.47K |
0.161x | -21.46% |
| 2014-12-31 | Nkr50.75 Million ≈ $5.34 Million |
Nkr10.37 Million ≈ $1.09 Million |
0.204x | +21.44% |
| 2013-12-31 | Nkr45.53 Million ≈ $4.79 Million |
Nkr7.66 Million ≈ $806.37K |
0.168x | -18.29% |
| 2012-12-31 | Nkr41.05 Million ≈ $4.32 Million |
Nkr8.45 Million ≈ $889.60K |
0.206x | +7.66% |
| 2011-12-31 | Nkr40.42 Million ≈ $4.25 Million |
Nkr7.73 Million ≈ $813.84K |
0.191x | -46.74% |
| 2010-12-31 | Nkr36.69 Million ≈ $3.86 Million |
Nkr13.18 Million ≈ $1.39 Million |
0.359x | +252.89% |
| 2009-12-31 | Nkr40.68 Million ≈ $4.28 Million |
Nkr-9.56 Million ≈ $-1.01 Million |
-0.235x | -152.99% |
| 2008-12-31 | Nkr49.53 Million ≈ $5.21 Million |
Nkr21.96 Million ≈ $2.31 Million |
0.443x | -1.84% |
| 2007-12-31 | Nkr54.36 Million ≈ $5.72 Million |
Nkr24.55 Million ≈ $2.58 Million |
0.452x | +11992.70% |
| 2006-12-31 | Nkr51.67 Million ≈ $5.44 Million |
Nkr193.00K ≈ $20.31K |
0.004x | +589.28% |
| 2005-12-31 | Nkr43.81 Million ≈ $4.61 Million |
Nkr23.74K ≈ $2.50K |
0.001x | +548.93% |
| 2004-12-31 | Nkr32.06 Million ≈ $3.37 Million |
Nkr-3.87K ≈ $-407.24 |
0.000x | +99.83% |
| 2003-12-31 | Nkr41.24 Million ≈ $4.34 Million |
Nkr-2.98 Million ≈ $-313.79K |
-0.072x | -170.45% |
| 2002-12-31 | Nkr43.84 Million ≈ $4.61 Million |
Nkr4.50 Million ≈ $473.53K |
0.103x | -- |
About ContextVision AB
ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image … Read more